title: Patient Count Projections for Advanced Melanoma by Line of Therapy and Other Clinical Characteristics in EU Countries: Results from The UK, Germany, France, Italy and Spain (EU-5).
authors.affiliation: Bristol-Myers Squibb, Rueil Malmasion, France.
authors.forename: B
authors.initials: B
authors.lastname: Gueron
authors.affiliation: Xcenda, LLC, Palm Harbor, FL, USA.
authors.forename: J K
authors.initials: JK
authors.lastname: Kish
authors.affiliation: Xcenda, LLC, Palm Harbor, FL, USA.
authors.forename: K
authors.initials: K
authors.lastname: O'Day
authors.affiliation: Xcenda, LLC, Palm Harbor, FL, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Martel
authors.affiliation: Bristol-Myers Squibb, Rueil Malmasion, France.
authors.forename: M
authors.initials: M
authors.lastname: Manley Daumont